Profile data is unavailable for this security.
About the company
Solarvest BioEnergy Inc. is a Canada-based algae biologics company. The Company’s production platform provides it with a flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. It has developed and patented Omega-3, which is ocean-based (Docosahexaenoic Acid (DHA) & Eicosapentaenoic Acid (EPA)) and organic. The products are produced without chemicals, solvents, and/or heavy processing that degrade the nutritional benefits. It offers a plant-based and sustainable product while avoiding ocean-based toxins/pollutants or residual processing solvents. Its project focuses on cannabinoids, which implements a research and development program to produce cannabidiol (CBD), cannabigerol (CBG) and tetrahydrocannabinol (THC). It has also produced Bone Morphogenetic Protein (BMP) in micro algae. Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint.
- Revenue in CAD (TTM)520.00
- Net income in CAD-1.72m
- Incorporated2005
- Employees--
- LocationSolarvest BioEnergy Inc301 - 1228 Hamilton StreetVANCOUVER V6B 6L2CanadaCAN
- Phone+1 (604) 684-3323
- Fax+1 (604) 239-0728
- Websitehttp://www.solarvest.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaxil Bio Ltd | 0.00 | -254.00k | 1.38m | -- | -- | 1.54 | -- | -- | -0.0019 | -0.0019 | 0.00 | 0.0065 | 0.00 | -- | -- | -- | -20.18 | -65.45 | -25.06 | -116.22 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 56.51 | -- | -- | -- |
| Solarvest Bioenergy Inc | 520.00 | -1.72m | 1.53m | -- | -- | -- | -- | 2,933.97 | -0.0289 | -0.0289 | 0.00001 | -0.097 | 0.0005 | -- | 0.0301 | -- | -177.23 | -95.33 | -- | -3,099.07 | 57.69 | -- | -330,076.90 | -75,194.81 | -- | -8.39 | -- | -- | -4.85 | -- | -48.35 | -- | 1.70 | -- |
| Vitality Products Inc | 775.08k | -356.72k | 1.66m | -- | -- | -- | -- | 2.15 | -0.0086 | -0.0086 | 0.0187 | -0.0317 | 0.6812 | 1.01 | 5.32 | -- | -31.35 | -31.33 | -- | -- | 72.66 | 73.77 | -46.02 | -47.85 | 0.1874 | -315.87 | -- | -- | -3.92 | 14.64 | 12.87 | -- | -- | -- |
